RxDoctor Payments Data

Faizullah Syed

Internal Medicine · Sheffield, ALNPI 1902845589

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,938 of the $3,221 with a category attached, or 60.2%. Eli Lilly accounts for 79.9% of it on its own, with 19 other manufacturers making up the rest.

$3,221in general payments, 2019–2025

Across 94 payments — averaging $34.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$3K
  • Novo Nordisk$134
  • Indivior Inc.$97
  • AbbVie$63
  • Johnson & Johnson$50
  • GSK$45
  • plus $259 from 14 others
$396,973in research payments, 2019–2025

Across 35 payments — averaging $11,342 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$185K
  • Sanofi US Services Inc.$104K
  • AstraZeneca$70K
  • Astrazeneca AB$38K
  • Janssen Research & Development, LLC$12

What the payments were for

  • Travel & lodging$1,93860%
  • Food & beverage$1,28340%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,221 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama →

Other internal medicine in Sheffield

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →